A full-term male infant was born to a 33-year-old gravida 3, para 3 mother. The prenatal course was uncomplicated, without gestational diabetes; the mother received prenatal care at an out-of-state institution. At the delivery, however, the baby was notably macrosomic, with shoulder dystocia and perinatal distress requiring positive pressure ventilation.
The topic of hypoglycemia in neonates and children has generated significant debate of late, with the American Academy of Pediatrics (AAP) and the Pediatric Endocrine Society (PES) having advanced apparently conflicting guidelines. Here's what community pediatricians need to know to avoid overscreening healthy infants and children without discharging babies who may have glucose-regulation problems beyond the first days of life.
Hospital discharge for extremely low-birth-weight (ELBW) infants, defined as those born at 28 weeks or earlier and weighing less than 1000 g at birth, often means significant ongoing health challenges for these babies and their families.
For parents of a child with type 1 diabetes, hypoglycemia can be a scary—and fatal—complication, but a treatment is in development that gives parents and caregivers a new way to keep glucose levels in check.